PreprintAll rights reservedbioRxiv
Novel Target Combinations in Lung Squamous Cell Carcinoma proposed by the Emet AI Research Environment and supported by discovery stage experimentation
- 1Benchsci
Related
- Real-world comparative outcomes of first-line immune combinations (ICI-ICI vs ICI-TKI) in metastatic renal cell carcinoma with sarcomatoid features.
- Omics data discovery agents: Agent-supported retrieval, reanalysis, and synthesis of published omics data
- Limiter l’expérimentation animale n’est pas une recherche empêchée, mais une science libérée
- Learning dispositions as a lens for teaching socioscientific issues: Attitudes of university biology students towards animal experimentation
- Evolutionary rescue in toxic combinations of metal is dependent on metal interactions
BibTeX
@misc{soman2026novel,
title = {{Novel Target Combinations in Lung Squamous Cell Carcinoma proposed by the Emet AI Research Environment and supported by discovery stage experimentation}},
author = {J. Soman and A. Kundu and J. Newington and S. Wong and N. Desai and S. Leung and J. Cudini and F. Suarez and P. Grandsard},
howpublished = {bioRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.04.749404},
url = {https://www.biorxiv.org/content/10.64898/2026.09.04.749404v1},
}
RIS
TY - UNPB
TI - Novel Target Combinations in Lung Squamous Cell Carcinoma proposed by the Emet AI Research Environment and supported by discovery stage experimentation
AU - J. Soman
AU - A. Kundu
AU - J. Newington
AU - S. Wong
AU - N. Desai
AU - S. Leung
AU - J. Cudini
AU - F. Suarez
AU - P. Grandsard
PY - 2026
DA - 2026/09/04
PB - bioRxiv
DO - 10.64898/2026.09.04.749404
UR - https://www.biorxiv.org/content/10.64898/2026.09.04.749404v1
ER -